Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | ACLY | P53396 | 4/20 | 0.35 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1805112 | 0.95 | ALDH1A1 (0.37) | ALDH1A1L3MBTL1ACLYMCL1HPGD | |
| SCHEMBL1807246 | 0.88 | ALDH1A1 (0.39) | ALDH1A1L3MBTL1MCL1HPGDTSHR | |
| SCHEMBL1809167 | 0.87 | CA2 (0.38) | ALDH1A1L3MBTL1ACLYMCL1HPGD | |
| SCHEMBL1805115 | 0.85 | CA2 (0.42) | ALDH1A1L3MBTL1MCL1HPGDTSHR | |
| SCHEMBL1807605 | 0.84 | PTGES2 (0.42) | MCL1 | |
| SCHEMBL1803342 | 0.82 | ALDH1A1 (0.36) | ALDH1A1HPGDTSHRLMNACYP2C19 | |
| SCHEMBL1807248 | 0.81 | ALDH1A1 (0.39) | ALDH1A1L3MBTL1MCL1HPGDTSHR | |
| SCHEMBL1806033 | 0.81 | ALDH1A1 (0.37) | ALDH1A1L3MBTL1MCL1HPGDTSHR | |
| SCHEMBL1803078 | 0.80 | TAAR1 (0.42) | ALDH1A1L3MBTL1TSHRCYP1A2CYP3A4 | |
| SCHEMBL1803077 | 0.80 | ALDH1A1 (0.38) | ALDH1A1L3MBTL1MCL1HPGDTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8404036-B2 | Water-soluble near-infrared absorbing coloring matters and aqueous inks containing same | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2013-03-26 | — | — | US | disclosed |
| US-20110123784-A1 | WATER-SOLUBLE NEAR-INFRARED ABSORBING COLORING MATTERS AND AQUEOUS INKS CONTAINING SAME | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2011-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110123784-A1 | WATER-SOLUBLE NEAR-INFRARED ABSORBING COLORING MATTERS AND AQUEOUS INKS CONTAINING SAME | IK, RB1, COL1A1 | ALDH1A1 218/4885L3MBTL1 2085/4885ACLY 2836/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.